What is the formulation on the drug label below?

A. Oral tablet: Oral medications must pass through the gastrointestinal tract and undergo first-pass metabolism in the liver before entering systemic circulation, significantly delaying the onset of action compared to parenteral routes.
B. Intramuscular injection: IM injections are absorbed faster than oral or subcutaneous routes due to the rich blood supply in muscle tissue. The rate of absorption depends on factors such as blood flow to the muscle, the solubility of the drug, and the injection site. While faster than oral administration, it is still slower than IV.
C. Intravenous injection: IV administration delivers the drug directly into the bloodstream, resulting in immediate systemic availability and the fastest onset of action. This route bypasses absorption barriers entirely.
D. Subcutaneous injection: SC injections are absorbed more slowly than IM and IV routes because of the lower vascularity of subcutaneous tissue. Onset of action is delayed relative to other parenteral methods.

A. Second-generation antihistamines have shorter half-lives and require more frequent dosing compared to first-generation antihistamines: Second-generation antihistamines typically have longer half-lives, allowing once-daily dosing. They are designed for sustained action with improved compliance and fewer side effects.
B. First-generation antihistamines block both histamine and muscarinic receptors, while second-generation antihistamines primarily block histamine receptors: First-generation agents, such as diphenhydramine, cross the blood-brain barrier and exert anticholinergic effects by blocking muscarinic receptors. Second-generation antihistamines are more selective for peripheral H1 receptors, resulting in fewer CNS and anticholinergic side effects.
C. First-generation antihistamines are less likely to cause sedation compared to second-generation antihistamines: First-generation antihistamines are more likely to cause sedation because they easily penetrate the blood-brain barrier and affect central H1 receptors, unlike second-generation agents.
D. Second-generation antihistamines cross the blood-brain barrier, causing significant central nervous system effects: These medications are designed not to cross the blood-brain barrier significantly, which is why they are much less sedating and have minimal CNS effects compared to first-generation antihistamines.